January 19, 2022 I received the following email from QNTA
[{“ Happy New Year! I hope yours is off to a good start!
Today, the company published a press release on the submission of final clinical data to the DR Ministry of Health, so we are very close to a potential registration of Escozine as a COVID-19 treatment if approved. You can read that article below:
Additionally, similar announcements were made in _many_ Dominican publications, just a few of which are list below for your reference - more can be found online in Spanish:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.